Replies to post #449912 on Anavex Life Sciences Corp (AVXL)

[BAR123]

Failure is not whether or not a company hit all endpoints exactly. It is whether or not the FDA, the key opinion leaders and the patients/care givers believe that there is enough benefit to the patients to warrant approval. This is exactly what happened with Sarapta. The trial is a failure when the FDA says it is in the USA.